The global demand for Coronary Artery Disease Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.
Coronary artery disease (CAD) or coronary heart disease, or ischemic heart disease, is a common cardiovascular condition characterized by the narrowing or blockage of the coronary arteries, responsible for supplying oxygen-rich blood to the heart muscle. When they become narrowed or blocked, it restricts the flow of blood and oxygen to the heart.
The increasing prevalence and incidence of coronary artery disease, driven by the rise in risk factors such as obesity, sedentary lifestyles, hypertension, and diabetes, contribute to market growth. Additionally, the ageing population is a significant driver, as CAD is more common in older individuals. Changes in lifestyle, including unhealthy dietary habits and low physical activity, have led to a greater demand for preventive measures, diagnostic tests, and therapeutic interventions. Technological advancements have been instrumental in driving advancements in the coronary artery disease (CAD) market. These advancements have significantly improved diagnostic tools and introduced innovative treatment options, including drug-eluting stents and minimally invasive procedures. Ongoing research and development efforts aimed at understanding it, developing new therapies, and improving treatment outcomes are driving the market growth. Awareness campaigns, educational initiatives, and emphasis on preventive measures have raised public awareness and increased demand for diagnostic services and treatments. The availability of advanced healthcare infrastructure, supportive reimbursement policies, and timely interventions contribute to the CAD market's expansion.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of coronary artery disease. The growth and trends of coronary artery disease industry provide a holistic approach to this study.
This section of the coronary artery disease market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Diagnosis
By Treatment
By End-Users
By Distribution Channel
This section covers the regional outlook, which accentuates current and future demand for the Coronary Artery Disease market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the coronary artery disease market include Pfizer Inc., Amgen Inc., Cytokinetics, Inc., Hikma Pharmaceutical PLC., AbbVie Inc., Lupin Ltd., Wockhardt., Glenmark., Zydus Pharmaceutical Inc., Amneal pharmaceutical LLC., Accord Healthcare., Aurobindo Pharma Ltd., and LG Chem. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CORONARY ARTERY DISEASE – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Diagnosis
3.7.2 Market Attractiveness Analysis By Treatment
3.7.3 Market Attractiveness Analysis By End-Users
3.7.4 Market Attractiveness Analysis By Distribution Channel
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL CORONARY ARTERY DISEASE MARKET ANALYSIS BY DIAGNOSIS
5.1 Overview by Diagnosis
5.2 Historical and Forecast Data
5.3 Analysis by Diagnosis
5.4 Electrocardiogram Historic and Forecast Sales by Regions
5.5 Echocardiogram Historic and Forecast Sales by Regions
5.6 Stress Test Historic and Forecast Sales by Regions
5.7 Cardiac catheterization Historic and Forecast Sales by Regions
5.8 Heart CT Scan Historic and Forecast Sales by Regions
5.9 Others Historic and Forecast Sales by Regions
6 . GLOBAL CORONARY ARTERY DISEASE MARKET ANALYSIS BY TREATMENT
...